|
Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease |
Maddux F W, Shetty S, del Aguila M A, Nelson M A, Murray B M |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Maddux F W, Shetty S, del Aguila M A, Nelson M A, Murray B M. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease. Annals of Pharmacotherapy 2007; 41: 1761-1769 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Aged; Aged, 80 and over; Anemia /drug therapy /economics /etiology; Erythropoiesis /drug effects; Female; Health Care Costs /statistics & Health Services /economics /statistics & Hematinics /economics /therapeutic use; Humans; Insurance Claim Review; Male; Medical Records /statistics & Middle Aged; Multivariate Analysis; Outcome Assessment (Health Care); Prevalence; Renal Insufficiency, Chronic /complications /drug therapy /economics; Retrospective Studies; Treatment Outcome; United States; numerical data; numerical data; numerical data /utilization AccessionNumber 22007006638 Date bibliographic record published 31/03/2009 |
|
|
|